Institutional investors purchased a net $2.6 million shares of SGEN during the quarter ended March 2017 and now own 99.55% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
APO ASSET MANAGEMENT GMBH Bought 61.9 Thousand shares of Seattle Genetics Inc